Telix Q3 2024 Business Update – Quarterly Revenue Exceeds AU$200M

Barchart · 10/17 02:31

MELBOURNE, Australia, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today provides an update on its revenue and operational performance for the quarter ended 30 September 2024 (Q3 2024).

Read more at globenewswire.com